[Protective effect of ginsenoside Rg1 again PC-12 cells in OGD injury through mTOR/Akt/FoxO3 signaling pathway]

Abstract

Insights

Ginsenoside Rg1 protects PC-12 cells from oxygen-glucose deprivation (OGD) injury. It works by activating the mTOR/Akt/FoxO3 signaling pathway, reducing cell damage and improving viability.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Cell Biology

Background:

  • Oxygen-glucose deprivation (OGD) models neuronal injury.
  • PC-12 cells are a common model for studying neuronal damage.
  • Ginsenoside Rg1 is a compound with potential therapeutic properties.

Purpose of the Study:

  • To investigate the protective effects of ginsenoside Rg1 against OGD-induced injury in PC-12 cells.
  • To explore the role of the mTOR/Akt/FoxO3 signaling pathway in ginsenoside Rg1's protective mechanism.

Main Methods:

  • Established an OGD model in PC-12 cells.
  • Assessed cell viability using MTT assay.
  • Measured lactate dehydrogenase (LDH) release, superoxide dismutase (SOD) activity, and malondialdehyde (MDA) levels.
  • Analyzed protein expression of mTOR, Akt, and FoxO3 using Western blot.

Main Results:

  • OGD significantly inhibited PC-12 cell proliferation.
  • Ginsenoside Rg1 (20, 40 μmol/L) increased cell viability and SOD activity, while reducing LDH release and MDA content.
  • Rg1 counteracted OGD-induced decreases in mTOR and p-Akt(ser473).
  • OGD reduced FoxO3 phosphorylation, and Rg1 treatment modulated this effect.

Conclusions:

  • Ginsenoside Rg1 attenuates OGD-induced PC-12 cell injury.
  • The protective mechanism involves the activation of the mTOR/Akt/FoxO3 signaling pathway.